Cargando…

The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients

AIM: To investigate whether the recommendation to remove 15 lymph nodes that is used in the staging system is necessary to assess gastric cancer progression and to evaluate whether our metastatic lymph node ratio dividing method, adapted from the AJCC’s (American Joint Committee on Cancer) 7(th) TNM...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shi, Zhao, Bai-Wei, Li, Yuan-Fang, Feng, Xing-Yu, Sun, Xiao-Wei, Li, Wei, Zhou, Zhi-Wei, Zhan, You-Qing, Qian, Chao-Nan, Chen, Ying-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499537/
https://www.ncbi.nlm.nih.gov/pubmed/23166665
http://dx.doi.org/10.1371/journal.pone.0049424
_version_ 1782249984586940416
author Chen, Shi
Zhao, Bai-Wei
Li, Yuan-Fang
Feng, Xing-Yu
Sun, Xiao-Wei
Li, Wei
Zhou, Zhi-Wei
Zhan, You-Qing
Qian, Chao-Nan
Chen, Ying-Bo
author_facet Chen, Shi
Zhao, Bai-Wei
Li, Yuan-Fang
Feng, Xing-Yu
Sun, Xiao-Wei
Li, Wei
Zhou, Zhi-Wei
Zhan, You-Qing
Qian, Chao-Nan
Chen, Ying-Bo
author_sort Chen, Shi
collection PubMed
description AIM: To investigate whether the recommendation to remove 15 lymph nodes that is used in the staging system is necessary to assess gastric cancer progression and to evaluate whether our metastatic lymph node ratio dividing method, adapted from the AJCC’s (American Joint Committee on Cancer) 7(th) TNM staging system, is helpful for the patients with fewer than 15 harvested lymph nodes. METHODS: We performed a retrospective study of 1101 patients with histologically diagnosed gastric cancer who underwent a D2 gastrectomy at the Sun Yat-sen University Cancer Center between January 2001 and December 2010. The Kappa and Chi-squared tests were employed to compare the clinicopathological variables. The Kaplan-Meier method and Cox regression were employed for the univariate and multivariate survival analyses. RESULTS: In the trial, 346, 601 and 154 patients had 0–14, 15–30 and more than 30 lymph nodes harvested, respectively. The median survival times of patients with different lymph nodes harvested in N0, N1, N2 and N3a groups were 45.43, 54.28 and 66.95 months (p = 0.068); 49.22, 44.25 and 56.72 months (p<0.001), 43.94, 47.97 and 35.19 months (p = 0.042); 32.88, 42.76 and 23.50 months (p = 0.016). Dividing the patients who had fewer than 15 lymph nodes harvested by the metastatic lymph node ratio at 0, 0.13 and 0.40, the median survival times of these 4 groups were 70.6, 50.5, 53.5 and 30.7 months (p<0.001). After re-categorising these 4 groups into the N0, N1, N2, N3a groups, the histological grade, T staging, premier N staging, and restaged N staging were the independent prognostic factors. CONCLUSIONS: Large numbers of lymph nodes harvested in radical gastrectomy do not cause stage migration. For those patients with a small number of harvested lymph nodes, their stage should be divided by the metastatic lymph node ratio, referred to in the TNM staging system, to assign them an accurate stage.
format Online
Article
Text
id pubmed-3499537
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34995372012-11-19 The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients Chen, Shi Zhao, Bai-Wei Li, Yuan-Fang Feng, Xing-Yu Sun, Xiao-Wei Li, Wei Zhou, Zhi-Wei Zhan, You-Qing Qian, Chao-Nan Chen, Ying-Bo PLoS One Research Article AIM: To investigate whether the recommendation to remove 15 lymph nodes that is used in the staging system is necessary to assess gastric cancer progression and to evaluate whether our metastatic lymph node ratio dividing method, adapted from the AJCC’s (American Joint Committee on Cancer) 7(th) TNM staging system, is helpful for the patients with fewer than 15 harvested lymph nodes. METHODS: We performed a retrospective study of 1101 patients with histologically diagnosed gastric cancer who underwent a D2 gastrectomy at the Sun Yat-sen University Cancer Center between January 2001 and December 2010. The Kappa and Chi-squared tests were employed to compare the clinicopathological variables. The Kaplan-Meier method and Cox regression were employed for the univariate and multivariate survival analyses. RESULTS: In the trial, 346, 601 and 154 patients had 0–14, 15–30 and more than 30 lymph nodes harvested, respectively. The median survival times of patients with different lymph nodes harvested in N0, N1, N2 and N3a groups were 45.43, 54.28 and 66.95 months (p = 0.068); 49.22, 44.25 and 56.72 months (p<0.001), 43.94, 47.97 and 35.19 months (p = 0.042); 32.88, 42.76 and 23.50 months (p = 0.016). Dividing the patients who had fewer than 15 lymph nodes harvested by the metastatic lymph node ratio at 0, 0.13 and 0.40, the median survival times of these 4 groups were 70.6, 50.5, 53.5 and 30.7 months (p<0.001). After re-categorising these 4 groups into the N0, N1, N2, N3a groups, the histological grade, T staging, premier N staging, and restaged N staging were the independent prognostic factors. CONCLUSIONS: Large numbers of lymph nodes harvested in radical gastrectomy do not cause stage migration. For those patients with a small number of harvested lymph nodes, their stage should be divided by the metastatic lymph node ratio, referred to in the TNM staging system, to assign them an accurate stage. Public Library of Science 2012-11-15 /pmc/articles/PMC3499537/ /pubmed/23166665 http://dx.doi.org/10.1371/journal.pone.0049424 Text en © 2012 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chen, Shi
Zhao, Bai-Wei
Li, Yuan-Fang
Feng, Xing-Yu
Sun, Xiao-Wei
Li, Wei
Zhou, Zhi-Wei
Zhan, You-Qing
Qian, Chao-Nan
Chen, Ying-Bo
The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
title The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
title_full The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
title_fullStr The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
title_full_unstemmed The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
title_short The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
title_sort prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499537/
https://www.ncbi.nlm.nih.gov/pubmed/23166665
http://dx.doi.org/10.1371/journal.pone.0049424
work_keys_str_mv AT chenshi theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT zhaobaiwei theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT liyuanfang theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT fengxingyu theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT sunxiaowei theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT liwei theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT zhouzhiwei theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT zhanyouqing theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT qianchaonan theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT chenyingbo theprognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT chenshi prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT zhaobaiwei prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT liyuanfang prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT fengxingyu prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT sunxiaowei prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT liwei prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT zhouzhiwei prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT zhanyouqing prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT qianchaonan prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients
AT chenyingbo prognosticvalueofharvestedlymphnodesandthemetastaticlymphnoderatioforgastriccancerpatientsresultsofastudyof1101patients